Search

Your search keyword '"Murphy, D.M."' showing total 221 results

Search Constraints

Start Over You searched for: Author "Murphy, D.M." Remove constraint Author: "Murphy, D.M."
221 results on '"Murphy, D.M."'

Search Results

2. P245 Real-world elexacaftor/tezacaftor/ivacaftor(ETI) changes prospective sputum collection and microbiological reporting in a single centre pilot cystic fibrosis cohort

9. Paramagnetic species in catalysis research: A unified approach towards (the role of EPR in) heterogeneous, homogeneous and enzyme catalysis

10. Contribution of isoprene-derived organosulfates to free tropospheric aerosol mass

15. Measurements of the concentration and composition of nuclei for cirrus formation

16. P212 Real world Orkambi Long-term Leavers (ROLL) study - a prospective 6-month descriptive analysis to understand factors influencing choice of dual CFTR modulator therapy in patients with cystic fibrosis

19. Influence of sea-salt on aerosol radiative properties in the Southern Ocean marine boundary layer

21. Phenotype of airway epithelial cells suggests epithelial to mesenchymal cell transition in clinically stable lung transplant recipients

22. Mesoscale temperature fluctuations and polar stratospheric clouds

32. Structural state and redox behavior of framework Co (II) in CoIST-2: a novel cobalt-substituted aluminophosphate with AEN topology

33. Liquid phase oxidation of cyclohexane using bimetallic Au-Pd/MgO catalysts

34. Molybdenum blue nano-rings: an effective catalyst for the partial oxidation of cyclohexane

35. WS07.6 Investigating the gut microbiota of patients with cystic fibrosis (PWCF) and the effects of an altered gut microbiota on functionality and faecal metabolites – the CFMATTERS experience

36. WS04.3 A comparison of Toll-like receptor mediated innate immune response in children with cystic fibrosis and an age matched control cohort

37. 217 Medical outcomes post transition of clinical care from a paediatric cystic fibrosis care model to an adult cystic fibrosis care model – an Irish perspective

39. WS20.4 Clinical outcomes of Real-World Kalydeco (CORK) study – a prospective 12 month analysis addressing the impact of CFTR modulation on the cystic fibrosis lung

40. WS16.1 Clinical Outcomes of Real-World Kalydeco (CORK) study – Investigating the impact of CFTR potentiation on the intestinal microbiota, exocrine pancreatic function and intestinal inflammation prospectively over 12 months

41. 48 Altered gut microbiota in stable patients with cystic fibrosis (CF) compared to controls and its relationship with intravenous (IV) antibiotic usage and lung function

45. 37 Clinical outcomes of real world Kalydeco (CORK) study

48. Assessment of the rate of solid-phase gastric emptying in ponies by means of the C-13-octanoic acid breath test: a preliminary study

49. WS3.5 Clostridium difficile in adult cystic fibrosis (CF): Prevalence, ribotyping and toxigenic capability. A prospective study

50. 74 Improved tolerability, adherence and reduced intravenous (IV) antibiotic usage in CF patients receiving inhaled versus nebulised antibiotic prophylaxis. A real world comparison of tobramycin inhaled powder (TIP) and tobramycin inhaled solution (TIS)

Catalog

Books, media, physical & digital resources